Cost-Effectiveness Analysis of a New Second-Line Treatment Regimen for Advanced Intrahepatic Cholangiocarcinoma: Biomarker-Driven Targeted Therapy of Pemigatinib Versus 5-FU Chemotherapy. - Chueh, Chen-Han; Tsai, Yi-Wen; Chen, Zi-Rong; Shiu, Ming-Neng; Wen, Yu-Wen; Chiang, Nai-Jung (PharmacoEconomics, 2023)